Intended Use

RX-1 Sleep is a Software as a Medical Device (SaMD) to aid in the evaluation of sleep-related breathing disorders in adults suspected of having sleep apnea. It analyzes inputs from two FDA-cleared devices: the Rhythm Express RX-1 mini and a Viatom pulse oximeter, and provides biophysical parameters recorded and stored for presentation to a Healthcare Professional under their direction.

Technology

RX-1 Sleep uses two cloud-based static/locked deep learning AI models for apnea-hypopnea index (AHI) and sleep/wake classification based on inputs from the Rhythm Express RX-1 mini chest-worn ECG sensor and a finger-worn Viatom pulse oximeter. It also includes traditional signal processing of accelerometer data for respiratory effort and posture detection. Data are communicated securely via cellular/Wi-Fi and Bluetooth to a cloud server where analysis is performed and reports generated.

Performance

Clinical validation was performed against gold-standard polysomnography (PSG) involving 476 subjects in the VIVA-STAGES study. Performance metrics demonstrate high sensitivity and specificity for diagnosing mild to severe sleep apnea (AHI≥5, ≥15, ≥30), and good agreement with PSG measurements using Bland-Altman analysis. The device showed sensitivity around 87-91% and specificity in the range of 83-97% across various thresholds. Additional performance measures confirmed accurate detection of sleep/wake states, posture, and respiratory effort.

Predicate Devices

No predicate devices specified

Ready to Sharpen Your Edge?

Subscribe to join 11k+ peers who rely on RadAI Slice. Get the essential weekly briefing that empowers you to navigate the future of radiology.

We respect your privacy. Unsubscribe at any time.